NEOADJUVANT
Clinical trials for NEOADJUVANT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT trials appear
Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo before kidney cancer surgery shows promise in clinical trial
Disease control Recruiting nowThis study tests whether giving a combination of two drugs (axitinib and a PD-1 inhibitor) before surgery can help prevent kidney cancer from coming back in patients at high risk of recurrence. About 298 participants will be randomly assigned to receive either the drug combo foll…
Matched conditions: NEOADJUVANT
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated May 26, 2026 04:05 UTC
-
New drug combo shows promise in shrinking esophageal tumors before surgery
Disease control Recruiting nowThis study is testing a new drug called ivonescimab (AK112) combined with two chemotherapy drugs (albumin-paclitaxel and cisplatin) given before surgery for people with advanced esophageal cancer that can be removed. The goal is to see if this combination can shrink tumors enough…
Matched conditions: NEOADJUVANT
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated May 26, 2026 03:51 UTC
-
New drug combo shows promise in shrinking tough ovarian tumors before surgery
Disease control Recruiting nowThis study tests a new drug combination (carboplatin plus mirvetuximab soravtansine) given before surgery to people with advanced ovarian, fallopian tube, or peritoneal cancer that has a specific protein (FRα). The goal is to see if the treatment shrinks tumors enough to improve …
Matched conditions: NEOADJUVANT
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 18, 2026 12:07 UTC